Intrauterine Devices Market Sees Surge in Adoption Among Women Aged 21–34

Intrauterine Devices Market Set to Surpass USD 14.2 Billion by 2035 Amid Growing Demand for Long-Acting Reversible Contraception, Reports Transparency Market Insights

According to a new research publication by Transparency Market Insights, the global intrauterine devices (IUD) market is poised for robust growth over the next decade. Valued at US$ 4.7 billion in 2024, the market is projected to expand at a compound annual growth rate (CAGR) of 10.6%, reaching more than US$ 14.2 billion by 2035. This growth is fueled by increasing awareness of long-acting reversible contraception (LARC), supportive government initiatives, rising preference for hormone-free birth control options, and the advent of advanced IUD technologies.

For More Information:

https://www.transparencymarketresearch.com/intrauterine-devices-market.html

Technological Advancements and Policy Support Catalyzing Market Growth

Intrauterine devices are among the most reliable and cost-effective contraceptive methods available today. They offer long-term protection—ranging from 3 to 10 years—with minimal user intervention and high efficacy. The market comprises two primary product categories: Copper IUDs and Hormonal (Levonorgestrel) IUDs. Hormonal IUDs, which offer the dual benefit of contraception and menstrual symptom relief, dominate global sales.

According to the report, the increasing demand for safe, hormone-regulated reproductive health options has prompted significant product development. A recent innovation includes shape memory alloy-based IUDs, designed to reduce the risk of uterine wall perforation and improve positional stability.

One notable development includes Sebela Pharmaceuticals’ investigational Copper 175 mm² IUD, which demonstrated a 99.0% efficacy rate and 98.8% successful placement rate in its Phase 3 clinical trials conducted across 42 U.S. sites. The IUD received widespread positive feedback for its hormone-free formulation and long-term contraceptive performance.

Market Drivers and Trends

The market’s upward trajectory is supported by several key drivers:

• Rising Awareness Among Women: Increased access to credible information through public health campaigns, social media, and healthcare providers has empowered women to explore more sustainable contraceptive options. IUDs, with their long-term convenience and minimal maintenance, are increasingly seen as a favorable alternative to oral contraceptives or barrier methods.
• Government and NGO Initiatives: Governments across North America, Europe, and emerging markets are actively promoting family planning programs that include IUDs as part of essential reproductive health services. Programs such as Title X in the U.S., which provide affordable or no-cost contraception, have been critical in increasing access to IUDs.
• Product Advancements and Affordability: The recent launch of Yanae, a French-invented copper IUD, by 49Care in Canada in January 2025, exemplifies how innovation is making IUDs easier to insert and more comfortable, without increasing costs. Retailing at a competitive US$ 140, Yanae includes a specialized flexible inserter, reducing the need for instruments and streamlining clinical procedures.

Segment Insights

Product Type: Hormonal IUDs are the leading segment due to their dual functionality—offering both birth control and relief from heavy menstrual bleeding. Copper IUDs remain popular among women seeking hormone-free options, especially in markets with a strong preference for natural contraceptives.

Age Group: The 21–34 age group is the most significant contributor to market revenue. This demographic represents women in their prime reproductive years, many of whom seek dependable, long-acting contraception as they delay childbearing for career or personal reasons.

End Users: Gynecology clinics and hospitals account for the majority of IUD placements. However, community healthcare centers are gaining traction in rural and underdeveloped regions due to improved outreach, funding, and awareness campaigns.

Regional Highlights

North America leads the global IUD market, driven by a high degree of product acceptance, well-established healthcare infrastructure, and favorable reimbursement frameworks. The U.S. remains the largest market in the region, supported by insurance mandates under the Affordable Care Act, which ensure broad contraceptive coverage.

Europe follows closely, with countries like Germany, France, and the U.K. showing strong IUD adoption rates due to national health programs and physician advocacy. Meanwhile, Asia Pacific and Latin America represent rapidly emerging markets, spurred by urbanization, rising income levels, and evolving societal norms around family planning.

In India and China, government programs and international collaborations with agencies such as the World Health Organization (WHO) and the United Nations Population Fund (UNFPA) are expanding access to IUDs among underserved populations.

Competitive Landscape

The intrauterine devices market is moderately consolidated, with global and regional players competing based on product differentiation, partnerships, pricing, and distribution strategies. Major players profiled in the report include:

• AbbVie
• Bayer AG
• CooperSurgical Inc
• DKT INTERNATIONAL
• EUROGINE, S.L.
• Mona Lisa N.V.
• OCON Medical Ltd
• Pregna International Limited
• Prosan International BV
• SMB Corporation of India

These companies are increasingly collaborating with hospitals, gynecology clinics, and public health networks to improve market penetration. Recent developments, product launches, and strategic partnerships are detailed in the report to provide stakeholders with insights into the evolving competitive dynamics.

Future Outlook

As the global emphasis on reproductive autonomy and women’s healthcare intensifies, the intrauterine devices market is expected to remain on an upward growth trajectory. Product innovation, affordability, and broad-based education on the benefits of LARCs will be central to shaping the market’s future.

“The IUD market is undergoing a transformation driven by consumer empowerment, government policy, and clinical innovation. With global efforts to reduce unintended pregnancies and expand access to family planning, IUDs are at the forefront of a major shift in reproductive health,” said a lead analyst at Transparency Market Insights.

The full report includes a detailed breakdown of historical data (2020–2024), future projections (2025–2035), segmentation analysis, company profiles, and region-specific strategies. It is available in PDF and Excel formats, suitable for investors, healthcare providers, policy makers, and market participants looking to capitalize on this rapidly growing space.